Skip to content
← Full study record

NCT00049673 · MORE INFO

Limitations, agreements, and source contact

Thalidomide and Prednisone After Autologous Stem Cell Transplantation Multiple Myeloma · Source last updated 2023-09-13

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
false
restrictive Agreement
false
point Of Contact
email
jdancey@ctg.queensu.ca
organization
Canadian Cancer Trials Group
phone
613-533-6340
title
Director of Clinical Trials
Complete source fields
certain Agreement
pi Sponsor Employee
false
restrictive Agreement
false
point Of Contact
email
jdancey@ctg.queensu.ca
organization
Canadian Cancer Trials Group
phone
613-533-6340
title
Director of Clinical Trials

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice